Vaddi Krishna (CIK 1824633) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-03-27). Recent activity: Buy PRLD (675,000 shares), Buy PRLD (5,416 shares), Buy PRLD (15,000 shares), Buy PRLD (29,999 shares), Buy PRLD (9,106 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-27 | Prelude Therapeutics Inc (PRLD) | CEO | Buy | 675,000 | $465,750 |
| 2025-03-24 | Prelude Therapeutics Inc (PRLD) | CEO | Buy | 5,416 | $3,954 |
| 2025-03-24 | Prelude Therapeutics Inc (PRLD) | CEO | Buy | 15,000 | $10,950 |
| 2025-03-18 | Prelude Therapeutics Inc (PRLD) | CEO | Buy | 29,999 | $22,499 |
| 2025-03-18 | Prelude Therapeutics Inc (PRLD) | CEO | Buy | 9,106 | $6,830 |
| 2025-03-14 | Prelude Therapeutics Inc (PRLD) | CEO | Buy | 47,500 | $33,725 |
| 2025-03-14 | Prelude Therapeutics Inc (PRLD) | CEO | Buy | 50,000 | $36,000 |
Source: SEC Form 4 filings · as of 2025-03-27